"Resistant parasites" refers to microorganisms or organisms that have evolved to be unaffected by drugs or treatments that were once effective against them. These parasites are now able to survive and multiply, causing challenges in treating illnesses or infections they cause.
Full definition
Among other things, GPARC calls for halting the spread of
resistant parasites in Cambodia by strengthening malaria control locally, ramping up monitoring and surveillance to detect resistance, and investing in new research.
University of Melbourne Professor, Leann Tilley, an Australian Research Council Laureate Fellow at the Bio21 Institute, tested the new drug in red blood cells infected with parasites and found that it was as effective at killing the
artemisinin resistant parasites as it was for the sensitive parasites.
The superbugs - malaria parasites that can beat off the best current treatments, artemisinin and piperaquine - have spread throughout Cambodia, with even fitter multidrug
resistant parasites spreading in southern Laos and northeastern Thailand.
White warned, too loudly some say, that the loss of artemisinin could cause a repeat of the chloroquine disaster of the 1980s,
when resistant parasites spread from the Greater Mekong to Africa and millions died.
«We now see this very
successful resistant parasite lineage emerging, outcompeting its peers, and spreading over a wide area,» said Arjen Dondorp, of the Mahidol Oxford Tropical Medicine Research Unit in Thailand, who co-led the work.
Scientists worry that
if resistant parasites make their way to Africa, where the vast majority of malaria cases occur, mortality will soar.
Researchers have been tracking the spread of artemisinin -
resistant parasites first by looking for signs in patients, and later by using multiple mutations in the parasite's Kelch13, or K13, gene, as molecular markers for resistance.
In a paper published online by Nature this week, the team showed that one of the drugs, called T3.5, could restore the action of two quinolines in
resistant parasites at low levels; it could also cure mice with malaria by itself.
Monitoring parasite populations for a specific genetic background — in this case, a fixed set of four well - defined mutations in the fd, arps10, mdr2, and crt genes — could allow researchers to assess the likelihood of new resistance - causing mutations emerging in different locations, helping to target high - risk regions even
before resistant parasites take hold.
Whilst artemisinin
resistant parasites do appear to have migrated across national borders, this only happened on a limited scale and, in fact, the most widespread kelch13 mutation, C580Y, appeared to have emerged independently on several occasions.
«We found that
while resistant parasites are much better at surviving ART treatment than sensitive parasites, extending the ART treatment or adding a very low concentration of an anticancer drug is enough to completely reverse the resistance mechanism.»
However, we need to demonstrate in advance if parasite flow within Africa poses a risk to Madagascar, should artemisinin
resistant parasites arise on the mainland.»
While anti-malarial drugs exist, the emergence of drug -
resistant parasite strains remains a global health concern and no vaccine has been licensed to date.
A combination of the two provides a double whammy and could rescue the artemisinins as anti-malarials, restoring their activity
against resistant parasites.»
The study, published in Science, builds on a recent report that mutations in the gene — K13 — are frequently found in drug -
resistant parasites in Southeast Asia.
Eventually, this leads to a large population
of resistant parasites that can not be exterminated with current drugs.
Researchers also currently lack any quick lab tests to tell if a patient is infected with an artemisinin -
resistant parasite.
«Slow - clearing,
resistant parasites are not restricted to western Cambodia as everyone had hoped,» Anderson says.
If you want to select drug -
resistant parasites, maybe this is the best strategy,» he says.
Given the emergence of artemisinin resistance, these findings could potentially lead to the design of new treatments against drug -
resistant parasites.
future studies are needed to evaluate the preventive efficacy of DP in other areas, maintain surveillance for potential selection of drug -
resistant parasites, and evaluate the role of chemoprevention in the context of other available malaria control interventions such as the scale up of [insecticide treated nets] and use of indoor residual spraying of insecticides.»
«Current malaria treatment fails in Cambodia due to drug -
resistant parasites: New findings inform new WHO treatment guidelines that reinstate former first - line therapy.»
We synthesized over 200 analogues and, of those, 66 worked against
the resistant parasites.»
Krogstad said that the same biotechnology that helped the team develop the new drug has also identified similar drugs that also hold promise against drug -
resistant parasites.
In the early phases of the Vietnam War, nearly 10 percent of American soldiers came down with malaria; many cases were due to drug -
resistant parasites.
When drug - treated mice were infected only with resistant strains and the nutrient was limited,
the resistant parasites survived.
By taking advantage of competition between parasites inside a host, we managed to use an existing drug to successfully treat an infection, even when drug -
resistant parasites were already there.»
But when drug - treated mice were infected with both sensitive and
resistant parasites, limiting the nutrient stopped resistant parasites from growing at all — even when resistant parasites were initially present at far greater numbers than when they typically first appear in a host.
Mutations in the kelch13 gene were present, yet rare, in Africa but weren't associated with artemisinin resistance and lacked the genetic background present in artemisinin -
resistant parasites in Southeast Asia.
Taken together, these findings suggest that mutations in the K13 - propeller play an important role in determining artemisinin resistance, act as a molecular marker for artemisinin -
resistant parasites, and provide important clues into how resistance is developing in parasite populations in Southeast Asia.
«Our approach allows us to identify emerging populations of artemisinin -
resistant parasites, and monitor their spread and evolution in real time.
But when we investigated further we found three distinct sub-populations of drug -
resistant parasites that differ not only from the susceptible parasites, but also from one another.
«Public health authorities need rapid and efficient ways to genetically detect drug -
resistant parasites in order to track their emergence and spread,» says Dr Olivo Miotto, first author of the paper from Oxford University, Mahidol University in Thailand, and the MRC Centre for Genomics and Global Health.
Last year saw publications in Nature Genetics by Miotto and colleagues about multiple strains of artemisinin -
resistant parasites in Cambodia, and in Nature by Dr. Frédéric Ariey and colleagues from Institut Pasteur identifying a molecular marker of artemisinin resistance.
This provides scientists with a unique opportunity to compare resistant and sensitive parasites to look for genetic differences that may be contributing to
the resistant parasites» ability to tolerate the drug.
It is also now recognized as one of the world's most pesticide -
resistant parasites.